This week, we published a free downloadable resource titled Coronavirus (COVID-19) Executive Briefing by GlobalData, which covers the outbreak, its impact on the economy, and implications for specific sectors.

See the latest headlines from our publishers and partners. Of particular interest in this tumultuous time: a new white paper by Packaged Facts Assessing Coronavirus Pandemic Impacts on the Pet Industry.

In addition, be sure to read Kalorama Information's new article on the development of COVID-19 diagnostic tests.

Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

Professional services form a vast, growing market with a highly educated workforce and some of the world’s most valuable, recognized brands. Professional services encompass a broad range of segments including portfolio management & investment advice, legal services, banking, securities trading, tax preparation & accounting, and other services.

The coronavirus outbreak is moving quickly. In this time of uncertainty and rapid change, market research firms are weighing in to assess the impact on different market segments.

Access all our most recent blog posts and press releases, and get the latest insights and industry data, plus ongoing updates on the market impact of COVID-19. 

This week's topics include edtech conferences, Chinese pharmaceuticals, digital biomarkers, prepared food & delivery, toys & games, refractories in China and India, and other markets.

An increased usage of digital tools, including smartphones and wearables, among others, has led to an expansion in collected health information.

The health data gathered by these devices also includes biomarker-related data — objective signals that are medically relevant and can be highly insightful for formulating treatments for patients, especially those who are suffering from chronic diseases.

Every news service globally is focused on COVID-19 (the “coronavirus”) and how it will affect the global population, but what of the Chinese health system itself? How does this sector operate during “normal” times? What will drive and restrain Chinese health markets?

These are some of the questions we have been looking at over the past 6 months.

The coronavirus outbreak is dominating the news cycle, and our analysts are weighing in to assess the market ramifications. Be sure to check out Freedonia's COVID-19 Economic Impact Tracker for the latest news.

In our listings below, see all our most recent blog posts and press releases on a wide range of industry categories.

Organ-on-chips (OOCs) are small plastic devices with biocompatible microfluid chambers containing multiple live human cells in a 3D culture that stimulate key physiological functions of body organs. The organ-on-chip market has grown 70.5% since 2015, reaching nearly $41.6 million in 2019, according to a report by The Business Research Company.